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Items for this week’s EPI Update include: 
 West Nile virus activity increasing across Iowa 
 Legionellosis testing recommendations  
 CDC NARMS 2015 Human Isolates Surveillance Report 
 Toxigenic Vibrio cholerae O141 in Nebraska patient with Florida 
travel 
 In the news: Wild video - Rabid beaver attacks father, 7-year-old 
daughter kayaking on river 
 In the news: This plate gets young kids to eat more veggies, study 
finds 
 Infographic: Sleeping in contact lenses is risky 
 Meeting announcements and training opportunities 
 
West Nile virus activity increasing across Iowa 
There are currently nine confirmed human cases of West Nile virus infection in 
Iowa, and eight additional cases are under investigation. Non-human West Nile 
virus activity is also increasing with two reported equine cases and 28 positive 
mosquito samples. The West Nile virus season typically lasts from late summer 
into early fall. Please encourage patients to take steps to reduce their risk of 
exposure to West Nile virus through the fall. 
 
For more information on West Nile virus in Iowa, visit 
idph.iowa.gov/cade/disease-information/west-nile-virus.  
 
Legionellosis testing recommendations  
Late and missed diagnoses of Legionnaires’ disease can be fatal, so it is 
important to identify cases and potential sources of infection. There are multiple 
indications for testing patients with pneumonia for legionellosis including 
immunocompromised patients, patients with recent travel history, and patients 
with possible healthcare-associated pneumonia (onset two or more days after 
admission to facility). The recommended diagnostic tests for Legionnaires’ 
disease are culture of a lower respiratory specimen on selective media and the 
Legionella urine antigen test. Serological assays can be nonspecific, and a single 
positive antibody titer does not discriminate between Legionnaires’ disease and 
causes of pneumonia. 
 
Local public health departments investigating legionellosis cases should ask 
about travel and healthcare exposures in the 10 days before symptom onset. 
IDPH looks for multiple cases associated with specific locations and reports 
potential sources of travel and healthcare-associated disease occurring in other 
states to CDC. 
 
Legionnaires’ disease kills one in four of those who get it from a healthcare 
facility. Creating and using a water management plan as required by the Centers 
for Medicare and Medicaid Services can help prevent and remediate Legionella 
risk in healthcare facilities.  
 
For more information about legionellosis, visit www.cdc.gov/legionella/index.html.  
 
CDC NARMS 2015 Human Isolates Surveillance Report 
The National Antimicrobial Resistance Monitoring System (NARMS) represents a 
collaborative effort among state and local public health, CDC, USDA, and FDA to 
monitor trends in antimicrobial resistance among several key bacterial organisms 
that can be found in humans, animals, and retail meat products. The 2015 report 
provides a summary of findings from whole genome sequencing of Salmonella 
isolates. Key findings from the report include: 
 Among 65 ceftriaxone-resistant Salmonella isolates, 8 had a resistance 
gene that is rare in the U.S. and is often linked to international travel. 
 Decreased susceptibility to azithromycin (DSA) among Shigella increased 
to 9.8 percent in 2015. 
 Among nontyphoidal Salmonella, 5.8 percent of the isolates tested were 
not susceptible to ciprofloxacin, the highest percentage since testing 
began in 1996. 
 Among Enteritidis (the most common Salmonella serotype), 14 percent 
were not susceptible to ciprofloxacin, up from 8 percent in 2014. 
 
To view the full report, visit 
www.cdc.gov/narms/reports/annual-human-isolates-report-2015.html.  
 
Toxigenic Vibrio cholerae O141 in Nebraska patient with Florida travel 
A recent CDC MMWR article describes a reported case of toxigenic Vibrio 
cholerae O141 in a Nebraska resident with travel to Florida. V. cholerae 
serogroups O1 and O139 are toxigenic strains associated with epidemic cholera; 
however, other serogroups, such as O75 and O141, can also produce cholera 
toxin, leading to a cholera-like illness identified as vibriosis. Vibrio species are 
difficult to culture because they are not easily identified using routine enteric 
media and often require selective media. However, detection of Vibrio species 
might become more common with increased use of culture-independent 
diagnostic testing (CIDT) due to increased sensitivity. Some of these CIDT 
assays are designed to detect a subset of Vibrio species and might not identify 
all cases or only identify cases as vibriosis without species information. Cholera 
and vibriosis are more common in the Gulf Coast region of the U.S. and are 
related to exposure to freshwater sources and consumption of raw or 
undercooked shellfish. 
 
Laboratories are encouraged to send specimens identified through CIDT as 
Vibrio cholerae to SHL for reflex culture testing. 
 
To view the full article, visit 
www.cdc.gov/mmwr/volumes/67/wr/mm6730a7.htm?s_cid=mm6730a7_w.  
 
In the news: Wild video - Rabid beaver attacks father, 7-year-old daughter 
kayaking on river 
www.kcci.com/article/wild-video-rabid-beaver-attacks-father-7-year-old-daughter-
kayaking-on-river/22695511  
 
In the news: This plate gets young kids to eat more veggies, study finds 
www.cnn.com/2018/08/06/health/children-plate-vegetables-food-study/index.html  
 
Infographic: Sleeping in contact lenses is risky 
 
 
To view in full size, visit 
www.cdc.gov/mmwr/volumes/67/wr/mm6732a2.htm?s_cid=mm6732a2_e. 
 
Meeting announcements and training opportunities 
IDPH will be hosting the Influenza 2018-2019 Webinar for Hospital, Clinic, 
Laboratory, School, and Long-term Care Settings on September 19, 2018 at 
10:30 AM. The webinar will cover influenza activity and surveillance in Iowa, 
vaccine recommendations, laboratory specimen guidance, and antiviral treatment 
and prophylaxis for the 2018-2019 season. Those who register will get a link to 
the recording after the webinar. To register for the webinar, visit 
zoom.us/webinar/register/WN_NUODdhUYSpufXlCeYn9ZlA.   
 
Have a healthy and happy week! 
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